Medical Advisory Committee

 

THOMAS BAUER, MD

 

Thomas Bauer Dr. Bauer graduated from Jefferson Medical College and pursued his training in general surgery, research and cardiothoracic surgery at Thomas Jefferson university Hospital.  He served as the Chief of Thoracic Surgery at the Helen F Graham Cancer Center at Christiana Care Health System.  He currently serves at the Chief of Thoracic Surgery at Jersey Shore University Hospital and is the Medical Director of Thoracic Oncology at Meridian Health in the Hackensack Meridian Health System.

Dr. Bauer has lead numerous clinical trials and has partnered with industry through device and pharmaceutical investigative trials for many years.  He has authored over 100 manuscripts, chapter, abstracts and presentations related to thoracic surgery.  He has a special interest in lung cancer screening research and clinical trials.  His clinical expertise is in robotic minimally invasive thoracic surgery for the treatment of lung cancer, first rib resections, esophageal cancer, benign foregut surgery and diaphragmatic pacing and reconstruction.

 

D. KYLE HOGARTH, MD, FCCP

 

KYLE HOGARTH Dr. Hogarth is Associate Professor of Medicine in the Section of Pulmonary and Critical Care Medicine at The University of Chicago. He is the Director of Bronchoscopy and is heavily involved in the field of interventional bronchoscopy with numerous publications.

Dr. Hogarth received his medical degree at Case Western Reserve University School of Medicine in Cleveland, Ohio. He then completed a residency in Internal Medicine and a fellowship in Pulmonary and Critical Care at The University of Chicago. He has been published in the New England Journal of Medicine, Chest, and many other journals. He serves on the editorial board of CHEST, where he is the section editor for the podcast section.

 

EDWARD F. PATZ JR., MD

 

Edward F. Patz Dr. Patz is the James and Alice Chen Professor of Radiology and a Professor in Pharmacology and Cancer Biology at Duke University Medical Center. He began his training in High Energy Physics at Harvard University, received his MD from the University of Maryland, completed his residency and thoracic imaging fellowship at the Brigham and Women’s Hospital and Harvard Medical School, and then was appointed to the faculty in the Department of Radiology at the Brigham, Harvard Medical School, and the Dana Farber Cancer Institute. In 1991, he was recruited to the Thoracic Imaging section in the Department of Radiology at Duke.

Dr. Patz is a clinician–scientist, with projects that focus on early lung cancer detection, molecular diagnostics, and novel therapeutic strategies. He has participated in numerous clinical trials including the National Lung Screening Trial (NLST), and for over 20 years has been the principal investigator of a basic science laboratory exploring lung cancer biology.

 

ANIL VACHANI, MD

 

Anil Vachani Dr. Vachani received his medical degree from the University of California, San Francisco in 1996, after which he completed internal medicine and pulmonary/critical care training at the University of Pennsylvania. He also holds a Masters in Clinical Epidemiology from the University of Pennsylvania. He is currently an Associate Professor of Medicine in the Pulmonary and Critical Care Division at the University of Pennsylvania in Philadelphia, PA, where he serves as Director of the Lung Nodule Program, Co-Director of the Lung Cancer Screening Program, and Director of Bronchoscopy at the Philadelphia VA Medical Center. He serves on various committees for the American Thoracic Society and is the Vice-Chair of the Thoracic Oncology Network of the American College of Chest Physicians.

Dr. Vachani’s research is focused on the discovery and validation of early detection and treatment prediction biomarkers for lung cancer and mesothelioma. Additional areas of research include studies on the measurement of biomarkers from circulating tumor cells and circulating free DNA, Finally, he is conducting studies on population level uptake of genomic and genetic technologies for treatment decisions in lung cancer using cancer registry and claims data.